Insider Transactions in Q1 2023 at Marinus Pharmaceuticals, Inc. (MRNS)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 06
2023
|
Charles Austin |
SELL
Open market or private sale
|
Direct |
1,073
-16.9%
|
$6,438
$6.49 P/Share
|
Feb 06
2023
|
Elan Ezickson |
SELL
Open market or private sale
|
Direct |
750
-11.81%
|
$4,500
$6.56 P/Share
|
Feb 06
2023
|
Seth H. Z. Fischer |
SELL
Open market or private sale
|
Direct |
1,018
-14.45%
|
$6,108
$6.54 P/Share
|
Jan 26
2023
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+32.36%
|
-
|
Jan 26
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,648
+33.67%
|
-
|
Jan 26
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,375
+28.77%
|
-
|
Jan 26
2023
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
28,130
+35.05%
|
-
|
Jan 26
2023
|
Seth H. Z. Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+33.82%
|
-
|
Jan 26
2023
|
Elan Ezickson |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|
Jan 26
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
16,548
+31.98%
|
-
|
Jan 26
2023
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|
Jan 26
2023
|
Timothy M Mayleben |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+17.08%
|
-
|
Jan 26
2023
|
Christine Berni Silverstein |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
Jan 26
2023
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|